Retatrutride

Retatrutide is a next-generation, investigational peptide therapy designed to support weight loss, metabolic health, and blood sugar regulation. As a triple hormone receptor agonist, Retatrutide targets three key pathways—GLP-1, GIP, and glucagon receptors—to deliver comprehensive metabolic support.

How It Works

Retatrutide combines the benefits of:

• GLP-1 activation to reduce appetite, slow gastric emptying, and regulate blood sugar

• GIP activation to enhance insulin sensitivity and metabolic function

• Glucagon receptor activation to increase energy expenditure and promote fat metabolism

Potential Benefits

• Powerful support for weight loss

• Enhanced blood sugar control

• Improved metabolic flexibility

• Support for cardiovascular and liver health

Retatrutide is currently in clinical trials and is not yet approved by the FDA. It is intended for research and educational purposes only.